Effects of Tetracycline and Spectinomycin on the Tertiary Structure of Ribosomal RNA in the Escherichia coli 30 S Ribosomal Subunit

James W. Noah, Michael Dolan, Patricia Babin, Paul Wollenzien

Journal of Biological Chemistry · 1999 · 47 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Structural analysis of the 16 S rRNA in the 30 S subunit and 70 S ribosome in the presence of ribosome-specific antibiotics was performed to determine whether they produced rRNA structural changes that might provide further insight to their action. An UV cross-linking procedure that determines the pattern and frequency of intramolecular 16 S RNA cross-links was used to detect differences reflecting structural changes. Tetracycline and spectinomycin have specific effects detected by this assay. The presence of tetracycline inhibits the cross-link C967×C1400 completely, increases the frequency of cross-link C1402×1501 twofold, and decreases the cross-link G894×U244 by one-half without affecting other cross-links. Spectinomycin reduces the frequency of the cross-link C934×U1345 by 60% without affecting cross-linking at other sites. The structural changes occur at concentrations at which the antibiotics exert their inhibitory effects. For spectinomycin, the apparent binding site and the affected cross-linking site are distant in the secondary structure but are close in tertiary structure in several recent models, indicating a localized effect. For tetracycline, the apparent binding sites are significantly separated in both the secondary and the three-dimensional structures, suggesting a more regional effect. Structural analysis of the 16 S rRNA in the 30 S subunit and 70 S ribosome in the presence of ribosome-specific antibiotics was performed to determine whether they produced rRNA structural changes that might provide further insight to their action. An UV cross-linking procedure that determines the pattern and frequency of intramolecular 16 S RNA cross-links was used to detect differences reflecting structural changes. Tetracycline and spectinomycin have specific effects detected by this assay. The presence of tetracycline inhibits the cross-link C967×C1400 completely, increases the frequency of cross-link C1402×1501 twofold, and decreases the cross-link G894×U244 by one-half without affecting other cross-links. Spectinomycin reduces the frequency of the cross-link C934×U1345 by 60% without affecting cross-linking at other sites. The structural changes occur at concentrations at which the antibiotics exert their inhibitory effects. For spectinomycin, the apparent binding site and the affected cross-linking site are distant in the secondary structure but are close in tertiary structure in several recent models, indicating a localized effect. For tetracycline, the apparent binding sites are significantly separated in both the secondary and the three-dimensional structures, suggesting a more regional effect. A variety of antibiotics interact with the ribosome to inhibit protein synthesis within bacterial and eukaryotic cells (1Gale E.F. Cundliffe E. Reynolds P.E. Richmond M.H. Waring M.J. The Molecular Basis of Antibiotic Action. Wiley, London1981Google Scholar). The point of interruption in the translation cycle has been determined for some antibiotics (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar), making them useful in vitro to investigate the nature of elongation in protein synthesis. Some of these antibiotics have been footprinted on the ribosomal RNAs in 30 S and 50 S subunits and in the 70 S ribosome (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar) as well as on model oligomers designed to mimic local regions of 16 S rRNA (4Purohit P. Stern S. Nature. 1994; 370: 659-662Crossref PubMed Scopus (255) Google Scholar, 5Recht M.I. Fourmy D. Blanchard S.C. Dahlquist K.D. Puglisi J.D. J. Mol. Biol. 1996; 262: 421-436Crossref PubMed Scopus (235) Google Scholar). Sites of action have also been established by affinity and photoaffinity experiments (6Cooperman B.S. Press U.P. Ribosomes Structure, Function, and Genetics. University Park Press, New York1980: 531-554Google Scholar, 7Oehler R. Polacek N. Steiner G. Barta A. Nucleic Acids Res. 1997; 25: 1219-1224Crossref PubMed Scopus (51) Google Scholar). The binding sites frequently correspond to regions of the ribosome that are implicated by other experiments in ribosome function. In many cases, binding site assignments are supported by resistance-conferring mutations in 16 S and 23 S rRNAs (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar, 8Triman K.L. Adv. Genet. 1995; 33: 1-37Crossref PubMed Scopus (11) Google Scholar). Antibiotics, either directly by binding or indirectly through conformation alterations, must result in the inability of tRNA or translation factors to bind the ribosome or else inhibit some processes needed during translation. However, little is known regarding whether conformational perturbations accompany binding, even in instances in which detailed information supporting binding sites and the nature of translation interruption are known. UV cross-linking of the rRNA in the ribosome provides an opportunity to monitor changes in rRNA conformation and, consequently, the ribosome global structure. We have previously determined the identity of 14 UV-induced cross-links in 16 S rRNA within the 30 S subunit (9Wilms C. Noah J.W. Zhong D. Wollenzien P. RNA. 1997; 3: 602-612PubMed Google Scholar) and 15 cross-links in the 70 S ribosome (10Noah J. Wollenzien P. Biochemistry. 1998; 37: 15442-15448Crossref PubMed Scopus (15) Google Scholar). Because of the gel electrophoresis method used in the detection, all of these cross-links occur between nucleotides that are distant in the primary sequence. These cross-links occur because the partner nucleotides possess a suitable distance and geometry during the lifetime of the excited state (on the order of 1 μs; Ref. 11Budowsky E.I. Axentyeva M.S. Abdurachidova G.G. Simukova N.A. Rubin L.B. Eur. J. Biochem. 1989; 159: 95-101Crossref Scopus (34) Google Scholar); therefore, their frequency provides a method to screen substrates and other agents for their ability to affect ribosomal conformation. In this report, UV irradiation was repeated in the presence of 13 antibiotics to determine whether they produce measurable changes in the ribosome structure that might be related to their activity. These 13 antibiotics were known to bind either the 30 S or 50 S subunit. Some of these antibiotics have localized binding sites on 16 S rRNA, as determined by chemical probing, that are adjacent in the 16 S rRNA secondary structure to nucleotides that participate in cross-links and may affect the frequency of such contacts. Two of these antibiotics, spectinomycin and tetracycline, have discernible effects on the frequency of specific UV cross-linking sites in 16 S rRNA. The implications of these effects with respect to the antibiotic action are discussed. Escherichia coli 70 S ribosomes and ribosomal subunits were prepared according to Makhno et al. (12Makhno V.I. Peshin N.N. Semenkov Y.P. Kirillov S.V. Mol. Biol. 1988; 22: 528-537Google Scholar) and dissolved in CMN 1The abbreviations used are: CMN, 80 mm cacodylic acid, pH 7.5, 20 mmMgCl2, 100 mm NH4Cl, and 4 mm β-mercaptoethanol; BTBE, 30 mmbis(2-hydroxyethyl)iminotris(hydroxymethyl)methane, 30 mmboric acid, and 2.5 mm EDTA, pH 6.8. buffer. In some experiments, CMN buffer was used with Mg2+concentrations from 0.5 to 50 mm. 70 S ribosomes were prepared by reassociating equimolar amounts of 30 S and 50 S subunits and were free of mRNA or tRNA. Samples were incubated with the following concentrations of antibiotics (Sigma) that were previously determined to produce specific footprints in the 16 S rRNA or 23 S rRNA by chemical probing (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar, 3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar): (a) 5 × 10−6m neomycin, (b) 5 × 10−6m paromomycin, (c) 5 × 10−6m streptomycin, (d) 1 × 10−4m gentamycin, (e) 1 × 10−4m kanamycin, (f) 1 × 10−4m spectinomycin, (g) 2.5 × 10−4m tetracycline, (h) 5 × 10−6m erythromycin, (i) 5 × 10−6m thiostrepton, (j) 5 × 10−6m fusidic acid, (k) 5 × 10−6m chloramphenicol, (l) 5 × 10−6m viomycin, and (m) 1 × 10−4m hygromycin. Concentration series have also been investigated for tetracycline and spectinomycin. Samples were incubated for 30 min at 37 °C, placed on ice for 10 min, and irradiated at 4 °C for 20 min in a quartz cuvette with continuous stirring. Irradiation was performed with a 312 nm trans-illuminator (Fotodyne Corp.) as described previously (9Wilms C. Noah J.W. Zhong D. Wollenzien P. RNA. 1997; 3: 602-612PubMed Google Scholar). Sample concentrations were usually 1 μg RNA/μl, with the exception of samples for preparative separation, which were irradiated at 6 μg RNA/μl. RNA was recovered from the samples by proteinase K digestion, phenol extraction, and ethanol precipitation. The RNA was dephosphorylated with shrimp intestinal phosphatase and purified by proteinase K digestion, phenol extraction, and ethanol precipitation. 16 S rRNA was then isolated on a 1% agarose gel before 5′ end-labeling with [γ-32P]ATP by T4 polynucleotide kinase. Cross-linked 16 S rRNA was separated by gel electrophoresis on gels made with 3.6% acrylamide:bisacrylamide (70:1), 8.3 murea, and BTBE buffer as described previously (9Wilms C. Noah J.W. Zhong D. Wollenzien P. RNA. 1997; 3: 602-612PubMed Google Scholar). For analysis of cross-linking sites, the location of the bands containing un-cross-linked and cross-linked 16 S rRNA were detected with a PhosphorImager, and bands were cut out and eluted by ultracentrifugation through cushions containing 2 m CsCl and 0.2 m EDTA, pH 7.4, for 12 h at 40,000 rpm (13Wilms C. Wollenzien P. Anal. Biochem. 1994; 221: 204-205Crossref PubMed Scopus (16) Google Scholar). RNA pellets were redissolved in 250 μl of H20, phenol-extracted, and re-precipitated before further analysis. The cross-linking sites in separated 16 S rRNA were found by primer extension analysis using 11 DNA primers complementary to regions throughout 16 S rRNA (9Wilms C. Noah J.W. Zhong D. Wollenzien P. RNA. 1997; 3: 602-612PubMed Google Scholar). The frequency of cross-linking was determined from PhosphorImager data (ImageQuant; Molecular Dynamics Inc.) of duplicate independent experiments. To normalize for RNA loading, cross-link band intensity was referenced to the same cross-link band (C54×A353) in each respective lane. This reference band showed <10% variance in all lanes when referenced to the un-cross-linked 16 S rRNA parent band in the same lane. Six classes of antibiotics were examined in these experiments: (a) aminoglycoside (neomycin, paromomycin, streptomycin, gentamycin, kanamycin, spectinomycin, and hygromycin), (b) tetracycline, (c) macrolide (erythromycin), (d) peptide (thiostrepton and viomycin), (e) fusidic acid, and (f) chloramphenicol. The seven aminoglycosides, tetracycline, and the two peptide antibiotics are thought to bind primarily to the 30 S subunit, and the two peptide antibiotics also bind to the 50 S subunit (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar). Erythromycin and chloramphenicol bind exclusively to the 50 S subunit, and fusidic acid prevents the release of elongation factor G·GDP from the ribosome (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar). These last three antibiotics were included to test the possibility that an alteration in the 50 S subunit structure may induce changes in the structure of the 30 S subunit, within the 70 S ribosome. Both 30 S and 70 S ribosomes were irradiated in the presence of the listed antibiotics, and, with exceptions noted below, the effects were identical. In all instances in these experiments, empty ribosomes were used to avoid heterogeneity in the ribosomal state and to avoid the complication of possible substrate-mediated structure changes. In addition, previous characterizations of antibiotic binding sites (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar, 7Oehler R. Polacek N. Steiner G. Barta A. Nucleic Acids Res. 1997; 25: 1219-1224Crossref PubMed Scopus (51) Google Scholar) and our identification of UV cross-links in 16 S rRNA (9Wilms C. Noah J.W. Zhong D. Wollenzien P. RNA. 1997; 3: 602-612PubMed Google Scholar) have been performed on empty ribosomes. Tetracycline and spectinomycin were the only compounds tested that affected the cross-linking pattern of 16 S rRNA within 30 S subunits or 70 S ribosomes (Fig. 1). At 2.5 × 10−4m, the concentration used for chemical footprinting experiments (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar), tetracycline affected three identified cross-links and one incompletely identified cross-link. The third band from the top of the pattern, which was verified as C967×C1400, was completely inhibited. In this and other gels, there was some decrease in the intensity of the topmost band in the pattern, which was shown to contain U244×G894. The third band from the bottom of the gel, which was shown to contain the cross-link C1402×C1501, increased twofold in intensity in both 30 S subunits and 70 S ribosomes. The fourth band from the top also decreased in the presence of tetracycline. U534 is one part of this cross-link, but we have been unable to find a partner for it. At 1 × 10−4m, the concentration used for chemical footprinting experiments (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar), spectinomycin decreased the intensity of the cross-link found in the second band from the top (Fig. 1), which was shown to contain the cross-link C934×U1345, by 60%. Reverse transcription analyses of the regions of 16 S rRNA containing the cross-links affected by tetracycline are shown in Fig.2. A and B show the results of reverse transcription in the nucleotide intervals 212–265 and 866–914, respectively, in which differences were seen in the tetracycline sample. In lane 7 in each panel, the stops indicating cross-links at U244 and G894 decreased in the tetracycline sample relative to the control sample. C and Dshow the results of reverse transcription reactions in the nucleotide intervals 952–983 and 1387–1409. Lane 5 of each panel contains stops indicating that the cross-link C967×C1400 disappeared.E and F show the results of reverse transcription reactions in the nucleotide intervals 1390–1411 and 1491–1504.Lane 2 of each panel contains stops indicating that the cross-link C1402×C1501 increased in the presence of tetracycline relative to the control. The effects of tetracycline on cross-link intensity are the same in both 30 S subunits and 70 S ribosomes. Reverse transcription analysis of the cross-linked band affected by spectinomycin is shown in Fig. 3. The only reverse transcription stops affected by spectinomycin were in intervals 907–953 (A) and 1330–1365 (B). A decrease in the stops at 935 and 1346 in lane 6 of each panel indicates that the cross-link C934×1345 is affected. The decreases in intensity are consistent with the difference seen in the analytical gel pattern (Fig. 1). Titration experiments were performed with tetracycline to determine the concentration threshold on the 16 S rRNA tertiary structure (Fig.4). At concentrations between 2.5 × 10−4m and 1 × 10−5m, tetracycline specifically affects the cross-links noted above. There was no change in the frequency of any of the cross-links before the low concentration limit was reached. In the sample irradiated in the highest concentration of tetracycline, several cross-links were partially or completely inhibited; this is to the binding of tetracycline to the ribosome a decrease in cross-linking to the tetracycline Titration experiments were also performed at spectinomycin concentrations (Fig. These show that the decrease in the C934×U1345 cross-link is seen at or 1 × 10−6m spectinomycin, with a of cross-link frequency 1 × The effects of tetracycline and spectinomycin were determined in 30 S subunits and 70 S ribosomes at concentrations from 0.5 to 50 mm. has been shown to the frequency of cross-linking of several cross-links C967×C1400 and C1402×C1501 (10Noah J. Wollenzien P. Biochemistry. 1998; 37: 15442-15448Crossref PubMed Scopus (15) Google Scholar). C967×C1400 was at all that in 0.5 in 30 S the frequency of the cross-link, even in the control was low to The in the frequency of C1402×C1501 to tetracycline was seen in 30 S subunits and 70 S ribosomes at all concentrations 5 mm. 5 no in C1402×C1501 be seen The decrease in frequency of C934×U1345 to spectinomycin change the concentration C1402×C1501, and identified in the of 16 S rRNA in gel electrophoresis (10Noah J. Wollenzien P. Biochemistry. 1998; 37: 15442-15448Crossref PubMed Scopus (15) Google Scholar). There was a possibility that and affect the of in that However, no changes in the analytical gel electrophoresis experiments these antibiotics were were any changes seen in primer extension experiments the 13 antibiotics examined in this tetracycline and spectinomycin showed specific and structural effects in 16 S rRNA that were by the UV cross-linking assay. The of cross-links by these antibiotics well with their known concentrations Y.P. Makhno V.I. Kirillov S.V. PubMed Scopus Google Scholar, C. R. J. J. Mol. Biol. 1996; PubMed Scopus Google Scholar), indicating that the 16 S rRNA tertiary structure effects are to the of subunit during translation. For the tetracycline all three of the cross-links are affected at the same tetracycline Tetracycline has been shown to inhibit protein synthesis by with the binding of to the ribosomal (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar, Y.P. Makhno V.I. Kirillov S.V. PubMed Scopus Google Scholar), but the binding of to the P. Eur. J. Biochem. PubMed Scopus Google Scholar). However, tetracycline has been to with binding (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar, S. S. A. PubMed Scopus Google Scholar). In a in which the binding of a of tetracycline, was of by and by was P. 1987; PubMed Scopus Google Scholar). Tetracycline have an inhibitory on the when the was at S and this was to a of ribosomes that bind tRNA in the with affinity Eur. J. Biochem. PubMed Scopus Google Scholar). cross-linking experiments have shown that tetracycline cross-links primarily to protein S 7 and, to a S and S 4 B.S. Biochemistry. 22: PubMed Scopus Google Scholar). S 7 has been footprinted by both and experiments to the part of in 16 S rRNA Noller H.F. RNA. 1995; Google Scholar). recent experiments have determined that with tetracycline concentrations 4 × 10−5m, UV and irradiation tetracycline cross-linked to 16 S rRNA at nucleotides and of them R. Polacek N. Steiner G. Barta A. Nucleic Acids Res. 1997; 25: 1219-1224Crossref PubMed Scopus (51) Google Scholar). At concentrations of × 10−4m, cross-linking sites, one at are seen R. Polacek N. Steiner G. Barta A. Nucleic Acids Res. 1997; 25: 1219-1224Crossref PubMed Scopus (51) Google Scholar). In experiments at 1 × 10−4m, tetracycline produced a chemical in 16 S rRNA at nucleotide and a of nucleotides and (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar) a at to tetracycline was 1998; PubMed Google Scholar), which also indicates that this is to tetracycline function. for tRNA in the and D. Noller H.F. J. Mol. Biol. PubMed Scopus Google Scholar). Because two of the three affected UV cross-links and all three cross-links are with the tRNA binding is to tetracycline might with tRNA al. R. Biochemistry. 1994; 33: PubMed Scopus Google Scholar) have investigated binding and found that the and of the and the were both by tRNA to the This an by the tRNA or some change in the ribosome that on that the alteration of the by tetracycline may affect the binding of tRNA in the but may inhibit some conformational needed for tRNA binding to the The antibiotic binding sites (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar, 7Oehler R. Polacek N. Steiner G. Barta A. Nucleic Acids Res. 1997; 25: 1219-1224Crossref PubMed Scopus (51) Google Scholar) and the affected RNA cross-linking sites are in a 16 S rRNA three-dimensional model A. P. and P. which the of the containing the tetracycline and spectinomycin binding sites and the cross-links affected by their This model is from recent R. J. Mol. Biol. 1997; PubMed Scopus Google Scholar, A. S.C. J. Mol. Biol. 1994; PubMed Scopus Google Scholar, Noller H.F. RNA. 1996; Google Scholar) in several regions because information the UV cross-links C967×C1400 (9Wilms C. Noah J.W. Zhong D. Wollenzien P. RNA. 1997; 3: 602-612PubMed Google Scholar, J. Wollenzien P. Biochemistry. 1998; 37: 15442-15448Crossref PubMed Scopus (15) Google Scholar), and and cross-links D. Wollenzien P. RNA. 1998; PubMed Scopus Google Scholar). from and to are and respectively, and from and to with the are and In model R. J. Mol. Biol. 1997; PubMed Scopus Google Scholar), the to are and and the to are and In both models, the between the sites of cross-linking R. Polacek N. Steiner G. Barta A. Nucleic Acids Res. 1997; 25: 1219-1224Crossref PubMed Scopus (51) Google Scholar) and the nucleotide (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar) are to the nucleotide D. Noller H.F. J. Mol. Biol. PubMed Scopus Google Scholar). The of tetracycline × 12 Spectinomycin a structural change in that results in a decrease in the frequency of cross-link Spectinomycin a from chemical at and Fig. and a of at (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar). In addition, spectinomycin is by a at in 16 S rRNA. Because of a of to nucleotides and by a also spectinomycin (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar), the binding site is in In addition, was shown that to spectinomycin be in by an in the top of C. R. J. J. Mol. Biol. 1996; PubMed Scopus Google Scholar). The of cross-link C934×U1345 by spectinomycin for an between and The that contains the spectinomycin at and the nucleotides that the C934×U1345 cross-link at the of are in the model (Fig. The distance between these two regions is 12 in the model shown (Fig. with 20 in the and R. J. Mol. Biol. 1997; PubMed Scopus Google Scholar) A result is that spectinomycin has no on the cross-link, which is in close to both the site (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar) and the binding site in 16 S rRNA. In addition, there are no changes in the cross-links or all of which are in This indicates that spectinomycin is a global of the tertiary structure but some specific alteration of the structure the of and is known that spectinomycin with elongation factor binding during of protein synthesis (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar). has been shown that elongation factor with the 30 S subunit the Noller H.F. 1998; PubMed Scopus Google Scholar); therefore, also possible that the structural by spectinomycin elongation factor The gentamycin, neomycin, and 16 S rRNA nucleotides and and at (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar). These antibiotics are thought to induce by and to inhibit (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar). (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar) and 16 S rRNA nucleotides nucleotides in the and and nucleotide in 30 S subunits in 20 mm (3Moazed D. Noller H.F. Nature. 1987; 327: 389-394Crossref PubMed Scopus (967) Google Scholar, C. J. Mol. Biol. 1997; PubMed Scopus Google Scholar) and to 16 S rRNA of the in 20 and induce in both 16 S and 23 S rRNA viomycin, these are known to be at nucleotides and both antibiotics also inhibit and (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar). is thought that their binding the ribosome or (2Spahn C.M.T. Prescott C.D. J. Mol. Med. 1996; 74: 423-439Crossref PubMed Scopus (173) Google Scholar). of antibiotics an in this is possible that these antibiotics interact with only a local of the ribosome. the tertiary structure effects for the other antibiotics may be to detect by the may be only in the ribosome or may affect of the ribosome by the cross-links that are made by UV We for on the

References

26